Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)

SHA:603351 Revenue

Nanjing Well Pharmaceutical Group had revenue of 344.52M CNY in the quarter ending September 30, 2025, with 10.35% growth. This brings the company's revenue in the last twelve months to 1.31B, down -0.97% year-over-year. In the year 2024, Nanjing Well Pharmaceutical Group had annual revenue of 1.30B with 12.19% growth.

• Revenue (ttm): 1.31B
• Revenue Growth: -0.97%
• P/S Ratio: 2.81
• Revenue / Employee: 1.85M
• Employees: 711
• Market Cap: 3.70B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.30B	140.91M	12.19%
Dec 31, 2023	1.16B	44.83M	4.03%
Dec 31, 2022	1.11B	68.70M	6.59%
Dec 31, 2021	1.04B	306.24M	41.61%
Dec 31, 2020	736.06M	-144.69M	-16.43%